Masaru Matsuda
CIK 1798679 · See Remarks · last filed 2026-05-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.11M
Companies
2
Total Filings
34
Lifetime Open-Market Net
-$3.06M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARQT | See Remarks | 127,573 | $24.38 | $3.11M | -$3.06M | 28 | 2026-05-06 |
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | SVP, General Counsel | 20,049 | — | — | $0 | 6 | 2021-09-07 |
Recent Filings · Page 4 of 4
34 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-12 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +5,136 | -$264.1K | EDGAR |
| 2020-09-04 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +4,504 | -$65.9K | EDGAR |
| 2020-02-13 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +2,449 | -$33.6K | EDGAR |
| 2020-02-12 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–34 of 34
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.